EGMN -- Children and adolescents who are treated with antipsychotics are at higher risk than are adults for many adverse effects; therefore, proactive follow-up is critical, said a leading researcher in the field, Dr. Christoph U. Correll, who spoke at the annual congress of the European College of Neuropsychopharmacology.
